The Scientists and Academics Who Carry the Weight of Tobacco Harm Reduction
In my time in advocacy, I have “spoken” to scientists, clinicians, researchers and academics from across the tobacco harm reduction world, and one thing has become increasingly obvious to me: behind the public statements, journal articles and policy debates are human beings carrying enormous emotional strain. I have seen frustration, fear, exhaustion and quiet disillusionment from people who entered this field believing science and compassion would naturally align. I have watched respected professionals hesitate before speaking openly, carefully choosing words not because they lack confidence in the evidence, but because they understand the social and professional risks attached to saying the “wrong” thing. Some have privately expressed despair at the state of public discourse. Others have described feeling isolated within institutions they once considered intellectual homes. What struck me most was not anger, but sadness. A sadness that scientific inquiry itself increasingly feels constrained by politics, ideology and reputational fear.
There are too many to mention, but you know who you are.
Few areas of modern science expose the emotional life of scientists more clearly than tobacco harm reduction.
On the surface, the debate appears to be about evidence. Relative risk. Population health modelling. Smoking cessation rates. Youth uptake. Toxicology. Epidemiology. But beneath the data sits something far more human and far more volatile: fear, identity, status, tribal loyalty and moral conflict.
The scientists and academics working in tobacco harm reduction occupy one of the strangest positions in modern public health. Many entered the field because they genuinely wanted to reduce smoking-related disease and death. Many believed safer nicotine products represented one of the most significant public health opportunities in decades. Yet instead of being welcomed into tobacco control, many found themselves treated as ideological threats.
The emotional consequences of this are rarely discussed openly.
A scientist can spend an entire career inside traditional tobacco control institutions, believing they are part of a moral crusade against smoking. Their professional identity becomes deeply intertwined with that mission. Over the decades, the battle against Big Tobacco has evolved into more than a public health objective. It becomes a moral framework through which the world is understood.
Then tobacco harm reduction arrives and disrupts the emotional order of the system.
Suddenly, products that contain nicotine but dramatically reduce exposure to combustion begin helping smokers quit cigarettes. The old binary between “good public health” and “bad tobacco industry” becomes unstable. The moral simplicity disappears. And for many within tobacco control, this creates profound psychological discomfort.
Because once you accept that nicotine itself is not the primary killer, and that safer nicotine products may save millions of lives, an unbearable question emerges: what if some of the assumptions underpinning decades of tobacco control were incomplete?
That is not merely an intellectual challenge. It is an emotional and existential one.
Many scientists working in THR quickly discover that evidence alone does not protect them. In fact, evidence can become socially dangerous when it collides with institutional narratives.
Researchers who publish positive findings about vaping or other reduced-risk products often experience reputational hostility completely disproportionate to ordinary scientific disagreement. They are accused of being industry shills, tobacco apologists or corrupt actors. Their motives are questioned rather than their arguments. Their funding is scrutinised obsessively. Their credibility is attacked publicly.
The emotional pressure this creates is immense.
Imagine spending years researching smoking-related disease, believing you are helping save lives, only to find yourself ostracised by colleagues because your conclusions threaten institutional orthodoxy. Imagine watching your reputation slowly shift from respected researcher to suspected heretic simply because you refuse to say that all nicotine products are equally bad.
This is the hidden emotional landscape of THR academia.
Many researchers in this field exist in a permanent state of reputational vulnerability. They know that a single misplaced phrase on social media, a nuanced comment in an interview or a controversial publication can trigger outrage campaigns capable of damaging careers. They know invitations can disappear. Collaborations can dry up. Grant opportunities can quietly evaporate.
Some continue anyway because they genuinely believe the science matters more than the consequences. But courage comes at a psychological cost.
There is also a particular loneliness experienced by many THR scientists. They often find themselves rejected by the very public health communities they once considered home, while simultaneously refusing alignment with the tobacco industry itself. They exist in an uncomfortable liminal space where neither side fully trusts them.
This social isolation can become emotionally exhausting.
The public rarely sees this because scientific culture rewards emotional suppression. Researchers are expected to project calm objectivity at all times. Admitting fear or distress risks appearing weak or biased. So many scientists in THR carry enormous emotional burdens privately while maintaining the public performance of detached professionalism.
But beneath the surface lies exhaustion.
Exhaustion from constantly defending basic principles of risk reduction that are accepted almost everywhere else in medicine. Exhaustion from watching nuance disappear beneath moral panic. Exhaustion from seeing smokers deprived of accurate information because institutions fear losing control of the anti-smoking narrative.
One of the most psychologically corrosive aspects of the THR debate is the moral inversion many researchers experience. Scientists advocating for lower-risk alternatives often believe they are acting in the interests of smokers and public health. Yet they are frequently portrayed as enemies of public health by people who frame abstinence-only approaches as morally pure.
This creates deep moral conflict because many THR researchers genuinely see preventable suffering continuing unnecessarily.
When a scientist believes safer alternatives could reduce disease and death, watching governments suppress or distort information about relative risk can become emotionally devastating. Particularly when smoking rates stagnate, or illicit markets explode while policymakers continue insisting the strategy is working.
Over time, some researchers become disillusioned not only with tobacco control institutions but with academia itself.
They begin recognising that scientific systems are not purely truth-seeking environments. They are human systems shaped by incentives, status hierarchies, ideological commitments and fear. They realise that consensus is sometimes maintained socially long before it is maintained scientifically.
This is especially visible in countries like Australia, where the hostility toward tobacco harm reduction has become deeply institutionalised. Scientists or clinicians who publicly advocate pragmatic approaches often encounter extraordinary backlash despite international evidence supporting harm reduction strategies.
The emotional atmosphere surrounding the issue becomes so charged that even discussing relative risk can feel taboo.
And yet many THR academics continue speaking out despite the costs because they believe something larger is at stake than their careers.
They believe science itself is at stake.
Because once fear, ideology and reputational pressure begin determining which scientific conclusions are socially permissible, the integrity of scientific culture starts eroding. The problem is no longer merely tobacco policy. The problem becomes whether institutions still possess the emotional maturity required to tolerate complexity, uncertainty and dissent.
This is why the emotional life of scientists matters so much.
The public tends to imagine scientific debates as clean intellectual exercises. In reality, the THR debate often resembles a collision between competing moral identities, institutional fears and psychological loyalties. Data alone does not determine outcomes. Human emotion does.
The tragedy is that many of the scientists most viciously attacked in tobacco harm reduction are often motivated by profoundly humanitarian instincts. They look at smokers not as moral failures but as ordinary people deserving safer options. They believe reducing harm matters even if abstinence is not achieved. They see compassion where others see ideological compromise.
And for holding that view, many have paid an enormous personal and professional price.
The emotional life of scientists in tobacco harm reduction reveals something uncomfortable but important about academia and public health. Institutions frequently celebrate courage retrospectively while punishing it in real time. They praise dissenters from history while marginalising dissenters in the present.
What the THR debate exposes is that science is not only about evidence. It is about whether human beings inside institutions possess the psychological courage to follow evidence when doing so threatens status, belonging and moral certainty.
That is not simply an intellectual challenge.
It is an emotional one.
STAY STRONG!!!



Thanks for this Substack. You describe very accurately the conflicts scientists face when conducting research whose outcome (let's say does not "disprove") but places doubts or nuances to tobacco control. This is not exclusive of research whose outcomes are favorable (or at least more nuanced) on THR, it occurs also in other topics when research outputs produce discomfort to the mainstream in a controversial topic: in climate change, during COVID, on safety of chemicals and pesticides. Perhaps the orthodoxy is more rigid in orthodox opponents of THR than in holders of orthodoxy in other topics. Perhaps this can be explained by the fact that empiric evidence for the case of THR is so strong that the opposing orthodoxy must rely more and more on increasingly rigid non-scientific arguments (ideology, moral panics, denial, ostracism). I also agree with Alex Wodak: young scientists rising in the hierarchical ladder of academia are in a too weak position to conduct research that (let's say not "disproves") but places doubts or nuances on the established views.
I became involved in advocacy for smoke-free nicotine products replacing deadly cigarettes a few years after I retired in 2012. In that advocacy period, I had neither sought nor been offered any paid position. I could therefore say exactly what I wanted publicly without fear of being admonished by someone senior or losing a valued position. My only attachment has been to Harm Reduction Australia, an organisation which as a matter of principle does not accept funding from government. For several years, my advocacy work involved working closely with another doctor who had identical views about the critical importance of smoke-free nicotine products replacing deadly cigarettes. We funded all our travel and accommodation to discuss smoking and vaping policy with members of parliament. Mainstream media in Australia were keen to interview and quote tobacco harm reduction opponents but rarely interviewed or quoted us. That has improved slightly in recent years but not much. Most health and medical journals and publications in Australia accepted many papers opposed to tobacco harm reduction and rarely if ever accepted articles supportive of smoke-free nicotine products replacing deadly cigarettes. Fortunately, I had already had thirty years experience advocating for the application of harm reduction for psychoactive drugs including methadone treatment, needle syringe programs, drug consumption rooms, pill testing and naloxone distribution. This experience gave me the confidence that harm reduction would eventually triumph even if we had to face several years of ferocious resistance. My situation is very different from a young researcher or clinician with a mortgage on the family home and a few children where ‘saying what you mean and meaning what you say’ risks everything. I know that one day this will all be over. Some politicians will recognise that sky high cigarette excise cannot continue and will be replaced by moderate cigarette excise rates. Also a decision will be made sooner or later to make smoke-free nicotine products more available than deadly cigarettes.